Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
In our trial, HZ/su was found to reduce the risks of herpes zoster and postherpetic neuralgia among adults 70 years of age or older. (Funded by GlaxoSmithKline Biologicals; ZOE-...